SKSerhii Kernychnyi

Serhii Kernychnyi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Serhii Kernychnyi has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Filgrastim as an immunomodulatory adjunct in severe feline panleukope-nia: hematological, functional, and clinical outcomes

    by M. M. Zhelavskyi, S. P. Kernychnyi, M. O. Maryniuk, M. I. Tsvilikhovskyi, O. Ya. Dmytriv

    Feline panleukopenia (FPV) causes severe neutropenia and immunosuppression, leading to high mortality in kittens. Granulocyte colony‑stimulating factor (G‑CSF) is used to accelerate neutrophil recovery, but its effects on neutrophil functional activity in cats remain poorly characterized. Therefore, the present study aimed to evaluate the immunomodulatory effects of filgrastim (Zarzio®, Sandoz, Austria) as part of a combination treatment protocol in cats with naturally occurring FPV infection, with particular focus on (i) hematological recovery, (ii) neutrophil oxidative burst and phagocytic capacity, and (iii) clinical outcomes. Twenty‑four mixed‑breed cats (Felis catus, 2–9 months) with PCR‑confirmed FPV were randomly assigned to a control group (standard supportive therapy only, n = 12) or an experimental group (standard therapy plus filgrastim 5 μg/kg SC once daily for 5 days, n = 12). Blood was collected on days 0, 3, 5, 7, 14, and 21. Hematology (VetScan HM5, Abaxis, USA), biochemistry (VetScan V2, Abaxis, USA), spontaneous and stimulated nitroblue tetrazolium (NBT) reduction test, and clinical scores were assessed. Filgrastim significantly accelerated leukocyte and neutrophil recovery: by day 5, total leukocytes reached 8.34 ± 0.91 × 10⁹/L in the experimental group vs. 4.12 ± 0.67 × 10⁹/L in controls (P < 0.01). Importantly, the percentage of spontaneous NBT‑positive neutrophils increased from 8.1 ± 1.3 % at admission to 42.6 ± 3.8 % on day 5 in treated cats, while controls remained below 15 % (P < 0.001). Vomiting ceased 1.5 days earlier in the filgrastim group than in controls, and hospitalization duration was shorter (5.2 ± 0.4 vs. 8.7 ± 0.6 days, P < 0.01). The survival rate was 91.7 % in the filgrastim group vs. 66.7 % in the control group. No severe adverse events were recorded. Adjunctive filgrastim therapy not only restores neutrophil counts but also enhances their functional antimicrobial capacity, leading to faster clinical recovery and improved survival in FPV‑infected cats. Its use is recommended in cases of profound neutropenia (<0.5 × 10⁹/L) at diagnosis.

  • Open Access

    Clinical experience with ASD-based adjuvant therapy for wound regeneration in cats

    by M. M. Zhelavskyi, S. P. Kernychnyi, O. Ya. Dmytriv, T. V. Betlinska

    Wound healing in cats remains a clinically relevant challenge due to species-specific anatomical features, prolonged inflammatory responses, and a relatively high risk of delayed epithelialization. The present case report evaluated the clinical efficacy and systemic safety of topical application of ASD fraction 3 ointment as an adjuvant therapy for the treatment of a cervical skin wound in a cat, with particular emphasis on wound healing dynamics, inflammatory status, metabolic balance, and potential adverse effects. At the initiation of treatment (Day 1), the cat presented with an open, round wound located in the cervical region, measuring 4.75 cm in diameter. The wound surface exhibited moderate edema, hyperemia of the surrounding tissues, and serosanguineous exudation, consistent with the inflammatory phase of wound healing. Topical ASD fraction 3 ointment was applied according to the treatment protocol, and the animal was monitored through regular clinical examinations as well as serial hematological and biochemical assessments conducted on Days 1, 7, 14, and 21. By Day 7 of treatment, a marked reduction in wound size was observed, with the wound area decreasing to approximately 65–70 % of the initial value. This reduction was accompanied by a noticeable decrease in exudation, contraction of the wound margins, and formation of viable granulation tissue. By day 14, further wound contraction was recorded, with the residual wound area reduced to approximately 20–25 % of baseline, indicating active epithelialization and progression toward tissue repair. Complete clinical wound healing was achieved by Day 21, characterized by full restoration of skin integrity and the formation of a thin, elastic scar without signs of inflammation or local complications. Hematological evaluation at baseline revealed moderate leukocytosis with neutrophilia, reflecting an active localized inflammatory response. During the course of treatment, leukocyte counts and differential parameters progressively normalized, indicating effective resolution of inflammation. Biochemical analysis demonstrated transient hypoproteinemia and hypoalbuminemia at the initial stage, followed by gradual normalization during healing. Liver and renal function markers remained within physiological reference ranges throughout the observation period, suggesting the absence of systemic toxicity associated with the topical use of ASD fraction 3 ointment. In conclusion, topical application of ASD fraction 3 ointment was associated with favorable wound healing dynamics, controlled inflammatory response, maintenance of metabolic balance, and no detectable adverse systemic effects. These findings suggest that ASD-based topical therapy may represent a promising adjunctive option for wound management in cats, warranting further controlled and comparative studies.


  • Toxicological safety of a preparation based on sodium bicarbonate for European fall deer: Embryotoxicity, teratogenicity and carcinogenicity

    by T. A. Velesyk, M. V. Ageev, V. Yu. Ponomarenko, T. M. Suprovych, T. M. Karchevska, S. P. Kernychnyi, O. Ya. Dmytriv, S. A. Ponomareva, V. L. Shnaider, V. V. Zakharin

    The paper presents the results of a comprehensive toxicological assessment of the veterinary drug ‘Acidostop’ (solution for parenteral use) when administered to laboratory animals. ‘Acidostop’ is a drug that restores the alkaline state of the blood in European fallow deer. When administered intravenously, the content of bicarbonate in plasma increases, hydrogen ions are bound, and pH increases (buffer effect). The volume of circulating blood is replenished when it is lost, helping to dissolve mucus in respiratory catarrh. It has an expectorant and diuretic effect, which aids in removing toxins from the body. The study was conducted to determine the embryotoxicity, teratogenicity, and potential carcinogenicity of the drug, since these indicators are key to assessing the safety of veterinary drugs, especially during the period of animal pregnancy. The experiments were performed on white rats and mice. The drug was administered subcutaneously at a therapeutic dose of 2.5 ml/kg body weight and a five-fold dose of 12.5 ml/kg body weight in different periods of embryogenesis: preimplantation, implantation, and organogenesis, as well as during fetal development. The indicators of general, preimplantation, and postimplantation embryonic lethality, the condition of the placenta, and the development of the bone and internal organs of the fetus were assessed according to generally accepted methods. Carcinogenicity was determined by the micronucleus test on white nonlinear mice. The results of the study showed that in a therapeutic dose, the drug does not cause embryotoxic, mutagenic, and teratogenic effects. At the same time, the administration of a five-fold dose in the first period of pregnancy led to a significant increase in general and preimplantation lethality, which requires caution when using it in pregnant animals. The carcinogenic effect of the drug was not detected: the proportion of polychromatophilic erythrocytes with micronuclei in the bone marrow of mice remained within the physiological norm (0.117–0.133%). The data obtained indicate that ‘Acidostop’ is safe for use in therapeutic doses in veterinary practice; however, its use in pregnant animals should be accompanied by strict adherence to the recommended dosages.

  • Evaluation of subacute toxicity of injectable iron preparation upon repeated intramural administration in piglets

    by T. A. Velesyk, I. Yu. Kolinko, G. A. Paskevych, L. M. Fiialovych, T. M. Suprovych, T. M. Karchevska, S. P. Kernychnyi, S. V. Zhigalyuk, L. V. Kalynovska

    The paper presents the results of a study of the subacute toxicity of an injectable iron-based drug under conditions of repeated intramuscular administration to piglets. The experiment aimed to assess the clinical safety of the drug by analyzing its effect on the general physiological condition of the animals, as well as on blood parameters — hematological and biochemical. The experiment used three-day-old piglets that were administered the drug in three dosage levels: therapeutic, five times the dose, and ten times the dose. The injections were administered for three consecutive days, after which the piglets were observed for seven days. The general condition of the animals in most groups remained satisfactory, except for a slightly depressed reaction in animals receiving the maximum dose. As a result, a statistically significant increase in the content of hemoglobin, erythrocytes, and iron in the blood serum was established, which indicates the effective absorption of iron from the preparation. At the same time, the indicators of the functional state of the liver and kidneys remained within the physiological norm, which indicates the absence of hepato- and nephrotoxic effects. Even when using a tenfold dose, no clinically significant changes in key biochemical parameters were observed. The study confirms the low toxicity of the drug and the possibility of its safe use in practical animal husbandry. The drug does not require a withdrawal period for meat, which increases its attractiveness for producers. The results are a strong basis for further registration and widespread use of the drug in veterinary medicine. In further studies, it is advisable to focus on assessing the chronic toxicity of the injectable iron drug, its effect on reproductive function, and morphological changes in tissues at the injection site. Important areas are the study of the effectiveness of the drug for different ages and species of animals, as well as its interaction with other veterinary drugs, in particular tocopherol and antibiotics. Additionally, genetic and nutritional factors that may affect the sensitivity of animals to the drug should be investigated, and optimal regimens for its use should be determined

  • Open Access

    The role of melatonin in the regulation of the immune system and reproductive health: mechanisms and prospects for clinical application

    by M. M. Zhelavskyi, S. P. Kernychnyi, O. Ya. Dmytriv, T. V. Betlinska

    Melatonin is a multifunctional hormone with diverse physiological roles, particularly in immune regulation and reproductive health. While primarily synthesized by the pineal gland in response to the circadian rhythm, melatonin is also produced in extrapineal tissues such as the placenta, gastrointestinal tract, and reproductive organs, highlighting its systemic significance. Beyond its role in sleep-wake cycle regulation, melatonin exhibits potent antioxidant, anti-inflammatory, and immunomodulatory properties, making it essential for maintaining cellular homeostasis and overall physiological stability. In the immune system, melatonin contributes to both innate and adaptive immunity by modulating cytokine production, reducing oxidative stress, and enhancing immune cell activity. It plays a protective role against infections and inflammatory diseases by suppressing pro-inflammatory mediators such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) while promoting anti-inflammatory cytokines like interleukin-10 (IL-10). Additionally, melatonin influences immune tolerance, which is critical for preventing autoimmune responses and ensuring successful pregnancy. In females, melatonin improves oocyte quality, embryo development, and pregnancy outcomes by protecting ovarian follicles from oxidative damage, regulating steroidogenesis, and supporting placental function. Its role in fetal development is particularly significant, as it contributes to maternal-fetal circadian signaling, placental vascularization, and epigenetic modifications that influence gene expression. In men, melatonin contributes to spermatogenesis and improves sperm quality by boosting mitochondrial activity, decreasing oxidative stress, and safeguarding sperm DNA from damage. Additionally, it helps regulate hormone production in the testes, maintaining optimal reproductive health. Given its pleiotropic effects, melatonin holds substantial therapeutic potential for addressing immune dysfunction, reproductive disorders, and pregnancy complications. Future research should focus on clinical applications of melatonin supplementation in treating infertility, pregnancy-related complications, and immune-mediated diseases. Understanding the intricate relationship between melatonin, immunity, and reproduction may pave the way for innovative therapeutic strategies in both human and veterinary medicine. Melatonin is a multifunctional hormone with essential roles in immune regulation and reproductive health. Beyond its well-known function in circadian rhythm regulation, melatonin exerts potent antioxidant, anti-inflammatory, and immunomodulatory effects. It plays a critical role in maintaining immune homeostasis by reducing oxidative stress, modulating cytokine production, and enhancing immune cell function, thereby offering protection against infections and inflammatory disorders. In reproduction, melatonin influences key processes such as oocyte maturation, embryo development, and pregnancy maintenance. It supports fertility by improving ovarian function, regulating gonadotropin secretion, and protecting reproductive tissues from oxidative damage. Additionally, melatonin's involvement in placental function and fetal development highlights its significance in ensuring successful gestation. Given its widespread physiological effects, melatonin presents promising therapeutic potential for addressing immune-related and reproductive disorders. Future research exploring its clinical applications may lead to novel strategies for enhancing reproductive success and immune resilience in both human and veterinary medicine.


  • Canine Mast Cell Tumors: Clinical Signs, Laboratory Diagnosis, Treatment, and Prognosis

    by Mykola Zhelavskyi, Serhii Kernychnyi, Tatiana Zakharova, Tamara Betlinska, Maksym Luchkа

    Canine mast cell tumors, a tumor originating from mast cells involved in allergic reactions and inflammation, are among the most common skin tumors in dogs. The present study aimed to explore the clinical features, diagnostic approaches, and prognosis of canine mastocytomas through a case study. A 5-year-old male Akita, weighing 35.8 kg, was brought to the Doctor VET veterinary clinic in Kamianets-Podilskyi, Ukraine, for evaluation. Upon initial examination, the dog had a body temperature of 38.5°C, a heart rate of 74 beats per minute (bpm), and a respiratory rate of 28 breaths per minute, all of which were within normal physiological limits. The animal was alert and responsive and displayed no signs of systemic distress. A detailed physical examination revealed a tumor located 35.2 mm below the plantar surface of the tarsal joint (art. tarsi). The tumor was round, mobile, and surrounded by a thin fibrous capsule, with no signs of pain or discomfort during palpation. Cytological analysis showed a high-cellularity smear with numerous mast cells scattered throughout the field. These cells were round to oval in shape with abundant cytoplasm containing dense, basophilic to metachromatic granules. The hematological evaluation indicated a systemic inflammatory or immune response triggered by the tumor, as evidenced by neutrophilic leukocytosis (73.1%; 8.89×10⁹/L). Biochemical analysis revealed an elevated alkaline phosphatase activity level (4.45 μmol/L), suggesting systemic involvement. The tumor was surgically excised, ensuring complete removal with wide margins to minimize the risk of recurrence. Histological examination of the excised tissues confirmed a densely cellular neoplastic infiltrate composed predominantly of mast cells arranged in sheets and clusters. The mast cells displayed significant cellular and nuclear pleomorphism, characterized by moderate to marked anisocytosis and anisokaryosis. While no significant necrosis was observed, scattered apoptotic bodies were present, indicating ongoing cellular turnover. This case highlighted the critical importance of early diagnosis and comprehensive management of canine mastocytomas. Low-grade tumors often carry a favorable prognosis when treated promptly and appropriately. However, higher-grade or poorly differentiated tumors may require multimodal therapeutic approaches to achieve better outcomes.


  • Fertility Restoration in Progestogen-Treated Hungarian Wirehaired Vizslas: Effects of GnRH Agonist on Reproductive Activity

    by Mykola Zhelavskyi, Serhii Kernychnyi, Valerii Tsvilikhovskyi, Volodymyr Mizyk, Tamara Betlinska, Maksym Luchkа

    Deslorelin implants are increasingly utilized in veterinary reproductive management as a reversible alternative to surgical sterilization in dogs. The present study evaluated the biphasic response to deslorelin (Suprelorin®, 4.7 mg; Virbac®, France) in Hungarian Wirehaired Vizsla bitches after long-term progestogen-induced estrus suppression and assessed its efficacy for estrus induction and hormonal response sterilization. Thirty healthy bitches, aged 2-3 years and weighing from 19.8 to 23.7 kg, were enrolled in the study, which was divided into three groups, including a control group (C1) and two experimental groups (E1 and E2), each comprising 10 bitches. All of these dogs received subcutaneous deslorelin implants during anestrus. In E1, bitches previously treated with medroxyprogesterone acetate for 18 to 24 months received the implant for estrus induction, which was surgically removed on day 7. In E2, the implant was used for prolonged estrus suppression. Cytology and hormone analysis samples (progesterone, luteinizing hormone) were collected from the cephalic vein at specific time points; during anestrus (day 160), before implantation in controls, proestrus (day 3), estrus (days 1-3), the flare-up phase (72 hours post-implantation), and post-removal (day 7, group E1). Diestrus was monitored on days 7, 9, 11, 14, 15, 30, and 60 for the E2 group under suppression. Cytological assessment was performed using Diff-Quik™ staining, and hormone levels were measured via chemiluminescent immunoassay and ELISA. Ultrasonography and physical examination were used to monitor reproductive tract status. The present study confirmed a biphasic response to deslorelin, characterized by an initial flare-up phase, during which luteinizing hormone (LH) levels and estrous behavior were elevated, peaking on days 3 or 4, followed by effective suppression from day 14 through day 60. Implant removal in group E1 successfully induced fertile estrus, demonstrating Suprelorin's utility for fertility restoration in progestogen-treated bitches. In group E2, the implant provided sustained reproductive suppression for up to 12 months without adverse effects. These results highlighted the dual role of deslorelin in inducing or suppressing estrus, providing a valuable, evidence-based pharmacological option for managing canine reproduction.

  • Open Access

    Паразитарні захворювання собак в умовах міської популяції

    by А. Б. Мушинський, Т. М. Карчевська, С. П. Керничний, Л. Б. Савчук, Т. В. Бетлінська

    Гельмінтози, спричинені паразитичними червами, залишають актуальною проблемою ветеринарної медицини, особливо в контексті здоров’я тварин в Україні. Метою роботи було з’ясування поширеності паразитарних захворювань собак, спричинених гельмінтами і найпростішими, в умовах міста Камʼянець-Подільський Хмельницької області. Об’єктами дослідження були службові, домашні та бездомні собаки м. Камʼянець-Подільський. Серед собак було виявлено п’ять видів гельмінтів та один вид найпростіших: один вид з класу Cestoda (Dipilidium caninum – 15,6 %); чотири види з класу Nematoda (Toxocara canis – 40 %, Toxascaris leonina – 15,1 %, Ancylostoma caninum – 4,8 %, Dirofillaria repens – 2,4 %) і один вид найпростіших (Giardia spp. – 13,4 %). У 17,4 % уражених тварин паразитарні інвазії реєстрували у вигляді мікст- і поліінвазій. Серед найпоширеніших комбінацій спостерігали поєднання анкілостомозу і токсокарозу (9,7 %), діпілідіозу і токсокарозу (12,9 %), а також у деяких тварин виявляли три і більше членів паразитоценозів. Досить часто разом із гельмінтами виявляли найпростіших (26 %). Найвищий відсоток ураження спостерігався серед бездомних тварин. За результатами досліджень було встановлено, що найбільш поширеними серед собак були токсокароз, токсаскаридоз та дипілідіоз, менш поширені – анкілостомоз, дирофіляріоз і лямбліоз. У щенят (до 6 місяців) частіше реєстрували токсокари та анкілостоми. У молодих собак (6 місяців – 2 роки) до них додавалися стронгілоїди та цестоди. Дорослі собаки (2–7 років) та літні (старше 7 років) були уражені токсокарами, анкілостомами, цестодами і дирофіляріями. За даними досліджень, можна зробити висновок, що самки, у яких ЕІ склала 55,1 %, більш інвазовані гельмінтами у порівнянні з кобелями, у яких ЕІ склала 44,9 %.

  • Open Access

    Gastrointestinal parasites of dogs, analysis of prevalence and treatment efficacy

    by A. B. Mushynskyi, T. M. Karchevska, S. B. Prosyanyi, S. P. Kernychnyi, L. B. Savchuk

    The study of the prevalence of gastrointestinal parasites in dogs and the efficacy of anthelmintic drugs is a pressing issue in veterinary medicine. Helminthic infections can affect various systems of the animal's body, including the gastrointestinal tract, lungs, and other organs, often leading to severe diseases. This article presents the results of an examination of 97 dogs aimed at identifying gastrointestinal parasitic infections and evaluating the efficacy of various anthelmintic drugs. The analysis of fecal samples revealed that 53 % of the dogs were infected with one or more species of parasites. Four species of parasites were identified: three species of helminths (Toxocara canis, Ancylostoma caninum, Uncinaria stenocephala) and one species of protozoan parasite (Giardia spp.). The highest prevalence of infection was recorded for T. canis (51%), and mixed infections involving two or more parasites were found in 27 % of the dogs. The study demonstrated a significant age-related variation in infection rates: puppies (≤ 6 months) had the highest prevalence (61 %), while the rates in young dogs (6 months – 1 year) and adult dogs (over 1 year) were 57.1 % and 26.4 %, respectively. Among the parasites affecting puppies, T. canis (45.4 %) and Giardia spp. (12.6 %) were the most prevalent, indicating their high susceptibility to these infections. Additionally, it was found that female dogs were more frequently infected with parasites than males. The efficacy of anthelmintic drugs varied depending on the type of infection. The drugs Brovadazole and Wormidex were 100 % effective in cases of mono-infections; however, their efficacy decreased in cases of mixed infections. The efficacy of Albentabs ranged from 32 % to 61 % in mixed helminth infections but reached 100 % in mono-infections. Metronidazole was found to be 100 % effective against the protozoan parasite Giardia spp. The results of this study highlight the importance of early diagnosis and appropriate treatment of gastrointestinal parasitoses in dogs, especially in puppies, to prevent severe complications. The efficacy of anthelmintic drugs can vary significantly depending on the type of infection and the number of parasites, underscoring the need for an individualized approach to treating animals. Combining different classes of anthelmintic drugs may be more effective than using a single drug, as this approach allows for broader coverage of diseases and reduces the risk of resistance development.


  • Open Access

    СУЧАСНІ МЕТОДИ ВИКЛАДАННЯ ВЕТЕРИНАРНОГО АКУШЕРСТВА, ГІНЕКОЛОГІЇ ТА БІОТЕХНОЛОГІЇ ВІДТВОРЕННЯ ТВАРИН ДЛЯ ЗДОБУВАЧІВ ВИЩОЇ ОСВІТИ

    by С. П. Керничний

    Veterinary reproductive medicine in today's world requires a high level of professional training and skills when it comes to the health and life of animals. With the passage of time and the development of modern technologies, teaching methods for students of veterinary faculties of higher education institutions are also changing. Educational institutions are actively implementing new approaches and technologies to train future veterinarians so that they are ready for modern challenges in the field of animal husbandry. The last decade is characterized by the rapid introduction of a large number of virtual technologies in various spheres of human activity. The author describes innovative technologies aimed at increasing the effectiveness of education, helping students to acquire comprehensive knowledge and skills necessary for successful practice in the veterinary field; the means of ensuring students' access to modern learning technologies, which enable higher education institutions to respond to the challenges of modern times and to form qualified specialists capable of implementing innovations in the field of veterinary medicine, are substantiated. In particular, such tools and technologies as virtual reality allow students to experiment and skillfully perform manipulations without real risks to animals, which helps to avoid possible errors and unforeseen complications in the future, including increasing the safety of practicing doctors, improving psychomotor skills of students and reducing the risks of errors during real procedures . The article substantiates the combination of distance and face-to-face learning, the wide use of interactive lectures, simulation simulators and 3D technologies, multimedia materials, online resources, etc. in the educational process. Ветеринарна репродуктологія в сучасному світі вимагає високого рівня професійної підготовки та навичок у випадках, коли йдеться про здоров'я та життя тварин. З плином часу та розвитком сучасних технологій змінюються і методи викладання для студентів ветеринарних факультетів закладів вищої освіти. Освітні інституції активно впроваджують нові підходи та технології для навчання майбутніх ветеринарних лікарів, щоб вони були готові до сучасних викликів у сфері тваринництва. Останнє десятиріччя характеризується стрімким впровадженням великої кількості віртуальних технологій у різні сфери діяльності людини. Автором описано інноваційні технології, що спрямовані на підвищення ефективності навчання, допомагають студентам отримати комплексні знання та навички, необхідні для успішної практики у ветеринарній сфері; обґрунтовано засоби забезпечення доступу студентів до сучасних технологій научання, які дають змогу закладам вищої освіти відгукуватись на виклики сучасності та формувати кваліфікованих фахівців, здатних впроваджувати інновації у галузі ветеринарної медицини. Зокрема, такі засоби і технології як віртуальна реальність дозволяють студентам експериментувати та вправно виконувати маніпуляції без реальних ризиків для тварин, що допомагає уникнути можливих помилок та непередбачених ускладнень у майбутньому, включаючи підвищення безпеки практикуючих лікарів, покращення психомоторики студентів та зменшення ризиків помилок під час реальних процедур. У статті обґрунтовано поєднання дистанційного та очного навчання, широкого використання у освітньому процесі інтерактивних лекцій, симуляційних тренажерів та 3D-технологій, мультимедійних матеріалів, онлайн-ресурсів тощо.